Goldman Sachs Group Inc Harvard Bioscience Inc Call Options Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HBIO
# of Institutions
97Shares Held
30.6MCall Options Held
700Put Options Held
2.1K-
Black Rock Inc. New York, NY2.84MShares$6.09 Million0.0% of portfolio
-
Punch & Associates Investment Management, Inc. Edina, MN2.77MShares$5.93 Million0.44% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.72MShares$5.81 Million0.87% of portfolio
-
Amh Equity LTD2.39MShares$5.11 Million8.88% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$4.61 Million0.0% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $89.1M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...